263 related articles for article (PubMed ID: 37410228)
1. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.
Mokou M; Narayanasamy S; Stroggilos R; Balaur IA; Vlahou A; Mischak H; Frantzi M
Methods Mol Biol; 2023; 2684():59-99. PubMed ID: 37410228
[TBL] [Abstract][Full Text] [Related]
2. A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.
Mokou M; Lygirou V; Angelioudaki I; Paschalidis N; Stroggilos R; Frantzi M; Latosinska A; Bamias A; Hoffmann MJ; Mischak H; Vlahou A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255925
[TBL] [Abstract][Full Text] [Related]
3. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
[TBL] [Abstract][Full Text] [Related]
4. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
Hudson ML; Samudrala R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
[TBL] [Abstract][Full Text] [Related]
5. Decoding Connectivity Map-based drug repurposing for oncotherapy.
Zhao Y; Chen X; Chen J; Qi X
Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37068308
[TBL] [Abstract][Full Text] [Related]
6. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
7. Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
Pulley JM; Rhoads JP; Jerome RN; Challa AP; Erreger KB; Joly MM; Lavieri RR; Perry KE; Zaleski NM; Shirey-Rice JK; Aronoff DM
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():333-352. PubMed ID: 31337270
[TBL] [Abstract][Full Text] [Related]
8. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
9. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
Front Immunol; 2021; 12():687975. PubMed ID: 34276676
[TBL] [Abstract][Full Text] [Related]
10. Signature-based approaches for informed drug repurposing: targeting CNS disorders.
Shukla R; Henkel ND; Alganem K; Hamoud AR; Reigle J; Alnafisah RS; Eby HM; Imami AS; Creeden JF; Miruzzi SA; Meller J; Mccullumsmith RE
Neuropsychopharmacology; 2021 Jan; 46(1):116-130. PubMed ID: 32604402
[TBL] [Abstract][Full Text] [Related]
11. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
12. Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.
Fortney K; Griesman J; Kotlyar M; Pastrello C; Angeli M; Sound-Tsao M; Jurisica I
PLoS Comput Biol; 2015 Mar; 11(3):e1004068. PubMed ID: 25786242
[TBL] [Abstract][Full Text] [Related]
13. An Omics Strategy for Translational Bioinformatics and Rapid COVID-19 Drug Repurposing.
Revikumar A
OMICS; 2023 Mar; 27(3):109-115. PubMed ID: 36854133
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing for cancer.
Banerjee J; Tiwari AK; Banerjee S
Prog Mol Biol Transl Sci; 2024; 207():123-150. PubMed ID: 38942535
[TBL] [Abstract][Full Text] [Related]
16. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
17. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
Zador Z; King AT; Geifman N
PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
[TBL] [Abstract][Full Text] [Related]
18. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Bladder Cancer-related Genes Using Integrative Heterogeneous Network Modeling of Multi-omics Data.
Peng C; Li A; Wang M
Sci Rep; 2017 Nov; 7(1):15639. PubMed ID: 29142286
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach.
Advani D; Kumar P
Neuropeptides; 2022 Dec; 96():102283. PubMed ID: 35994781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
